Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc., a leading biopharmaceutical company headquartered in the United States, focuses on developing innovative therapies for cancer and other serious diseases. Founded in 2010, Karyopharm has made significant strides in the industry, particularly with its flagship product, XPOVIO (selinexor), which targets the nuclear export protein XPO1 to enhance cancer treatment efficacy.
With a strong presence in the oncology sector, Karyopharm is dedicated to addressing unmet medical needs through its unique approach to drug development. The company has achieved notable milestones, including regulatory approvals and partnerships that bolster its market position. Karyopharm's commitment to advancing therapeutic options underscores its role as a key player in the biopharmaceutical landscape, striving to improve patient outcomes globally.
-20 vs industry average
Karyopharm Therapeutics Inc.’s score of 18 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Karyopharm Therapeutics Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Karyopharm Therapeutics Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Karyopharm Therapeutics Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Karyopharm Therapeutics Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project